FLC
ZYNE

Fifth Lane Capital’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Fifth Lane Capital’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100,000
Closed -$127K – 222
2023
Q3 		$127K Buy
+100,000
New +$127K 0.04% 59